Skip to content
MMJ Gazette
  Monday 12 January 2026
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
  • Home
  • News
  • CBD
  • Cannabis
  • Drugs
  • Marijuana
  • Tobacco
  • Law
Trending
January 10, 2026Cannabis Firms Face HR Compliance Crunch in 2026 January 9, 2026Oregon Cannabis Sales Drop in 2025 Despite Record Harvests January 8, 2026Kentucky’s Medical Weed Market Faces Major Supply Hurdles January 7, 2026Vireo Growth Buys Eaze in $47M Cannabis Shakeup January 5, 2026Chanda Macias Drives Global Medical Cannabis Access January 3, 2026Trump’s Marijuana Shift: Answers to Your Burning Questions on Tax Relief January 2, 2026Marijuana Rescheduling Sparks Tax Relief Hopes – But When? January 1, 2026Three Trends Reshaping U.S. Cannabis in 2026 December 30, 2025Trump’s Cannabis Shift Sparks Hope for Parkinson’s Relief December 24, 2025Anti-Weed Group Funds Bid to Kill Pot Sales in Maine, Mass
MMJ Gazette
MMJ Gazette
  • About
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Authors
MMJ Gazette
  Cannabis  Verano CEO Eyes Big Changes for Weed Business at MJBizCon
CannabisNews

Verano CEO Eyes Big Changes for Weed Business at MJBizCon

Lars BeckersLars Beckers—December 4, 20250
FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

George Archos, the head of marijuana giant Verano Holdings, has a simple wish this holiday season: treat his company like any other business. But roadblocks from the IRS and tech giants like Meta keep holding the industry back. As leaders gather at MJBizCon 2025, could real reform finally be on the way? Dive in to see what’s at stake.

The IRS treats cannabis companies differently, and that’s a huge pain for operators like Verano. Under Section 280E of the tax code, these businesses can’t deduct normal expenses like rent or payroll because marijuana remains a Schedule I drug federally. This rule forces them to pay taxes on gross revenue, not profits, which crushes margins.

Archos has spoken out about this in recent interviews. He calls it unfair and outdated, pushing for rescheduling to ease the burden. A 2024 Benzinga report highlighted his view that moving cannabis to Schedule III could be a game-changer, allowing standard deductions and boosting cash flow.

Verano, based in Chicago, reported heavy losses since going public in 2021, according to Crain’s Chicago Business in November 2025. Yet, the company stays optimistic. They operate in multiple states, and leaders say reforms could turn things around fast.

Data from the Tax Foundation shows cannabis firms pay effective tax rates up to 70% or more due to 280E. That’s way higher than other industries. Archos wants this fixed so his team can focus on growth, not tax fights.

Meta’s Ad Bans Stifle Growth

Social media giant Meta, which owns Facebook and Instagram, bans most cannabis ads. This blocks companies like Verano from reaching customers online, where billions shop daily. Archos points to this as a key barrier, saying it treats legal weed businesses like outlaws.

In a Yahoo Finance video from 2023, Archos explained how these rules hurt despite state-level legalization. He argues for fair play, letting cannabis firms advertise like alcohol brands do. Without it, marketing stays limited to in-person events or word-of-mouth.

Industry experts agree. A 2025 MJBizDaily article notes operators prepare for federal shifts, but tech policies lag. Verano has built a strong retail presence, with stores in states like Illinois and New Jersey, but online hurdles slow expansion.

One workaround? Partnerships and influencer deals, but they’re risky and less effective. Archos pushes for change, hoping rescheduling prompts Meta to update its rules.

This affects everyday users too. If ads were allowed, prices might drop due to better competition, making legal weed more accessible.

MJBizCon Spotlights Path Forward

At MJBizCon 2025 in Las Vegas, running December 2-5, Archos joins other leaders to tackle these issues head-on. The event, known as the cannabis world’s biggest gathering, focuses on deals, innovation, and reform talks.

Archos will discuss speeding up normal business treatment with minimal hassle. A recent MJBizDaily preview calls it the spot for networking and pushing boundaries. Verano’s recent win – a conditional license for Texas operations, announced December 2, 2025 – adds buzz to their presence.

Panels cover everything from rescheduling to banking woes. The SAFE Banking Act, stalled for years, could get new life, letting banks serve cannabis firms without fear.

Here’s what attendees might expect:

  • Talks on federal reform milestones, like easier research.
  • Networking for mergers and expansions.
  • Exhibits showcasing new tech to dodge current limits.

Verano’s growth story shines here. Founded by Archos in 2014, they snagged Illinois’ first license and now thrive in multiple markets.

But challenges persist. A 2025 Yahoo Finance piece quotes Archos on thriving despite headwinds, emphasizing adaptation.

Hope Grows Amid Ongoing Struggles

Not everything is bleak. Federal moves hint at progress. The DEA’s push to reschedule cannabis, discussed in a 2024 Benzinga exclusive with Archos, could slash taxes and open doors.

Verano eyes more states, like their Texas entry. This positions them for a post-reform boom, potentially turning losses into profits. A Crain’s report from November 2025 notes despite no profits yet, Archos has zero regrets, betting on long-term wins.

Industry-wide, sales hit $29 billion in 2023, per BDSA data, with growth projected to $40 billion by 2026 if reforms kick in.

Still, operators juggle state rules varying wildly. Archos stresses unity to push for change.

As the cannabis world watches MJBizCon 2025 unfold, George Archos stands at the forefront, demanding fair treatment for his industry. His persistent Christmas wish underscores a fight for equality that could reshape the market, lower costs for consumers, and spark economic growth in legal states. From tax relief to ad freedom, these changes promise a brighter future, but only if leaders act fast.

FacebookTwitterPinterestLinkedInTumblrRedditVKWhatsAppEmail

Lars Beckers

Lars Beckers is a distinguished senior content writer at MMJ Gazette, bringing a wealth of experience and expertise to the realm of medical marijuana and cannabis-related content. With a deep understanding of the industry and a passion for sharing knowledge, Lars's articles offer readers comprehensive insights and engaging narratives in the dynamic world of cannabis. Known for his meticulous research, clarity of expression, and commitment to delivering high-quality content, Lars brings a seasoned perspective to his work, educating and informing audiences on the latest trends and developments in the field.

Trump Edges Closer to Rescheduling Marijuana in Bold Federal Shift
Minnesota Cannabis Market Hits Roadblock with Transporter Shortage
Related posts
  • Related posts
  • More from author
Cannabis

Cannabis Firms Face HR Compliance Crunch in 2026

January 10, 20260
Cannabis

Oregon Cannabis Sales Drop in 2025 Despite Record Harvests

January 9, 20260
Marijuana

Kentucky’s Medical Weed Market Faces Major Supply Hurdles

January 8, 20260
Load more
Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

SEARCH
PROMOTIONS
RECENT POSTS
  • Cannabis Firms Face HR Compliance Crunch in 2026
  • Oregon Cannabis Sales Drop in 2025 Despite Record Harvests
  • Kentucky’s Medical Weed Market Faces Major Supply Hurdles
  • Vireo Growth Buys Eaze in $47M Cannabis Shakeup
  • Chanda Macias Drives Global Medical Cannabis Access
  • Trump’s Marijuana Shift: Answers to Your Burning Questions on Tax Relief
  • Marijuana Rescheduling Sparks Tax Relief Hopes – But When?
  • Three Trends Reshaping U.S. Cannabis in 2026
  • Trump’s Cannabis Shift Sparks Hope for Parkinson’s Relief
  • Anti-Weed Group Funds Bid to Kill Pot Sales in Maine, Mass
    © MMJ Gazette. 2024
    • About
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Authors